Navigation Links
Analyte Health Appoints Lawrence Leisure to its Advisory Board
Date:1/13/2014

CHICAGO, Jan. 13, 2014 /PRNewswire/ -- Analyte Health (http://www.analytehealth.com) announced today that Lawrence Leisure has joined its Advisory Board. Mr. Leisure comes with a wealth of experience within the health and managed care industries, and currently serves as a Life Sciences partner at Kleiner Perkins Caufield & Byers. He has held consulting leadership positions at Ingenix Consulting where he led their Payer & Employer Market Group, Accenture where he was the Global Managing Partner for the Health Vertical, and Towers Perrin where he led the Managed Care practice. In these various roles he also served as client partner to many of the largest US health plans and pharmacy benefit management organizations as well as a number of the largest global employers.

Mr. Leisure joins the Analyte Health Advisory Board and will be involved in providing strategic insights for new channel development, medical ecosystem partnerships, and the continued expansion of the company's Diagnostic Triage platform to other health conditions. "I have been invested in the acceleration of innovation in health care for many years. Analyte Health is positioned to be a leader in diagnostic triage and I am excited to work with the team to further develop its reach and impact," said Mr. Leisure.

Sridhar Murthy, CEO of Analyte Health said, "We are excited to welcome Lawrence Leisure to our Advisory Board. His wealth of experience and industry knowledge will provide an invaluable resource as we find new and effective ways to effectively and efficiently diagnose diseases early, and to triage these patients quickly to the appropriate care."

About Analyte Health, Inc.

Analyte Health is a diagnostic triage company. Its mission is to provide convenient access to education, diagnostic testing, personalized results and recommendations to consumers through its Online Clinics. Analyte Health offers access to healthcare via the phone and the web to a national team of doctors and partner diagnostic labs. Over 125,000 patients have trusted Analyte Health to deliver convenient and private STD testing and care. More information about the company is available at http://www.AnalyteHealth.com.

Forward-Looking Statements
Analyte Health, Inc. is a privately held company. This press release may be deemed to contain forward-looking statements, which are subject to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including statements regarding the expected benefits to consumers from using Analyte Health's services. Readers are cautioned that these forward-looking statements are only predictions and may differ materially from actual future events or results due to a variety of risks and uncertainties, including, among other things, the potential impact of regulatory and third party payer developments in the field of telehealth and STD testing, general business and economic conditions, changes in arrangements with vendors or suppliers, and costs or delays in obtaining or maintaining regulatory approvals and licenses. Any forward-looking statements in this release are based on limited information currently available to Analyte Health, which is subject to change, and Analyte Health will not necessarily update the information.


'/>"/>
SOURCE Analyte Health, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Diplomats CEO and CFO to co-present at J.P. Morgans Annual Healthcare Conference
2. Practice Fusion Partners with Healthagens Practice iQ to Help Physician Groups Perform as ACOs
3. Halozyme Therapeutics Provides an Update on Anticipated Milestones for 2014 at the 32nd Annual J. P. Morgan Healthcare Conference
4. Seres Health Announces Interim Clinical Data for SER-109 in Recurrent C. difficile
5. Concordia Healthcare Corp. announces FDA agreement on Special Protocol Assessment for Phase 3 Clinical trial on new therapy to treat perihilar cholangiocarcinoma
6. St. Vincent Health Selects Acupera to Improve Population Health and Team-based Care Delivery
7. Haemonetics Announces Signing of Supply Agreement with HemeXcel at J.P. Morgan Health Care Conference
8. Covance to Present at the 32nd Annual J. P. Morgan Healthcare Conference
9. Regulatory Oversight Significantly Impacting Spending at Benchmarked Healthcare Companies
10. WuXi PharmaTech Provides Update of 2013 Financial Guidance, to Present at J.P. Morgan Healthcare Conference
11. Rigel Will Present Clinical Product Portfolio Update at J.P. Morgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... , Dec. 2, 2016 The U.S. ... for Jardiance (empagliflozin) to reduce the risk of cardiovascular ... and cardiovascular disease. "Cardiovascular disease is ... 2 diabetes mellitus," said Jean-Marc Guettier , M.D., ... Products in FDA,s Center for Drug Evaluation and Research. ...
(Date:12/2/2016)... December 2, 2016 Persistence Market ... market in its upcoming report titled, "Global Market Study on Cardiac ... CAGR of -1.4% between 2016 and 2024". The global cardiac ... 2015 and this is likely to decline to US$ ... global cardiac pacemaker market is anticipated to exhibit a ...
(Date:12/2/2016)... 2016 According to the latest market ... on Automated Endoscope Reprocessors: Single Basin Automated Endoscope Reprocessors Product ... 2016 and 2024 " the global automated endoscope reprocessors market was valued at ... at a CAGR of 7.2% during an eight-year forecast period ... by 2024. ...
Breaking Medicine Technology:
(Date:12/2/2016)... ... December 02, 2016 , ... ... California, will be included in the 2016 “Guide to America’s Top Plastic Surgeons” ... on the amalgamation of their education, experience, and professional associations. , One ...
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... ... veterinarian diagnostic imaging systems and the first company to offer robotic ... a Heart at their tradeshow booth # 941 for the American Association of ...
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... ... journeys, announced today that it has raised $6.0 million in an initial round ... Clarify Health’s conviction that patients and their caregivers can receive far better care ...
(Date:11/30/2016)... ... November 30, 2016 , ... The ... been designated as a Cigna Infertility Center of Excellence. The Cigna Center of ... , “It’s an honor to be designated a Cigna Infertility Center of Excellence," ...
(Date:11/30/2016)... ... November 30, 2016 , ... ... health treatment has announced the opening of a new residential mental health treatment ... with mental health issues such as severe anxiety, depression, bi-polar disorder, and other ...
Breaking Medicine News(10 mins):